COLISTIN APSA 1,200,000 IU/G PREMIX FOR MEDICATED FEEDING STUFF FOR PIGS
Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
Karakteristik produk
(SPC)
16-07-2016
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
COLISTIN (AS SULFATE)
Tersedia dari:
Andres Pintaluba S.A.
Kode ATC:
QA07AA10
INN (Nama Internasional):
COLISTIN (AS SULFATE)
Dosis:
1,200,000 International Unit
Bentuk farmasi:
Premix for Med.Feedstuffs
Jenis Resep:
POM
Kelompok Terapi:
Porcine
Area terapi:
Colistin
Indikasi Terapi:
Antibiotics
Status otorisasi:
Authorised
Tanggal Otorisasi:
2016-07-01
Karakteristik produk
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
COLISTIN APSA 1,200,000 IU/g
Premix for medicated feeding stuff for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCE:
Colistin (as sulfate)
1,200,000 IU
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff
Granulated brown powder
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pig (piglet and pig for fattening).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment and metaphylaxis of enteric infections caused by non-invasive _E.coli _susceptible to colistin.
The presence of disease in the herd should be established before metaphylactic treatment.
4.3 CONTRAINDICATIONS
Do not use in horses, particularly in foals, since colistin, due to a shift in the gastrointestinal microflora balance could
lead to the development of antimicrobial associated colitis (Colitis X), typically associated with _Clostridium difficile_,
which may be fatal.
Do not use in case of hypersensitivity to colistin or to any of the excipients.
Do not use in case resistance to polymyxins.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As an adjunct to treatment, good management and hygiene practices should be introduced in order to reduce the risk of
infection and to control the potential build up of resistance.
Colistin exerts concentration-dependent activity against Gram-negative bacteria. Following oral administration high
concentrations are achieved in the gastrointestinal tract, i.e. the target site, due to the poor absorption of the substance.
These factors indicate that a longer duration of treatment than the one indicated in section 4.9, leading to unnecessary
exposure, is not recommended.
The intake of medicated feed by animals can be alter
Baca dokumen lengkapnya
